Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plitidepsin in Advanced Dedifferentiated Liposarcoma
NCT01876043Phase 2Terminated
- Sponsor
- Institut Bergonié
- Start
- Feb 2012
- Primary completion
- Apr 2015
- Modality
- Cyclic Peptides, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of plitidepsin in dedifferentiated liposarcoma (DDL), sponsored by Institut Bergonié. Started Feb 2012; status: terminated.
02
Drugs
plitidepsin
03
Conditions
dedifferentiated liposarcoma (DDL)
Beyond the preview
Go deeper on NCT01876043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01876043.